US3712947A - Compositions containing coumarin ether sun-screening compounds - Google Patents
Compositions containing coumarin ether sun-screening compounds Download PDFInfo
- Publication number
- US3712947A US3712947A US00165343A US16534371A US3712947A US 3712947 A US3712947 A US 3712947A US 00165343 A US00165343 A US 00165343A US 16534371 A US16534371 A US 16534371A US 3712947 A US3712947 A US 3712947A
- Authority
- US
- United States
- Prior art keywords
- coumarin
- compounds
- sun
- methyl
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract description 40
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title abstract description 34
- 239000000203 mixture Substances 0.000 title abstract description 32
- 235000001671 coumarin Nutrition 0.000 title abstract description 21
- 229960000956 coumarin Drugs 0.000 title abstract description 20
- 238000012216 screening Methods 0.000 title abstract description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 title description 6
- -1 COUMARIN ETHER COMPOUNDS Chemical class 0.000 abstract description 19
- 231100000344 non-irritating Toxicity 0.000 abstract description 6
- 230000009965 odorless effect Effects 0.000 abstract description 5
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 4
- 239000001257 hydrogen Substances 0.000 abstract description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 150000003842 bromide salts Chemical class 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001805 chlorine compounds Chemical class 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000001235 sensitizing effect Effects 0.000 description 6
- 230000000475 sunscreen effect Effects 0.000 description 6
- 239000000516 sunscreening agent Substances 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 150000004820 halides Chemical class 0.000 description 5
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Inorganic materials [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 5
- HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 125000001485 cycloalkadienyl group Chemical group 0.000 description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- GLCBOQQZRISLFQ-UHFFFAOYSA-N 4-methyl-7-prop-2-enoxychromen-2-one Chemical compound C1=C(OCC=C)C=CC2=C1OC(=O)C=C2C GLCBOQQZRISLFQ-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 125000003342 alkenyl group Chemical group 0.000 description 3
- 125000005082 alkoxyalkenyl group Chemical group 0.000 description 3
- 125000002877 alkyl aryl group Chemical group 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- RTORNQDWFDEDPT-UHFFFAOYSA-N 4-methyl-7-phenylmethoxychromen-2-one Chemical compound C1=CC=2C(C)=CC(=O)OC=2C=C1OCC1=CC=CC=C1 RTORNQDWFDEDPT-UHFFFAOYSA-N 0.000 description 2
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 2
- KWNHWLBNDYLDEC-UHFFFAOYSA-N 7-prop-2-enoxychromen-2-one Chemical compound C1=CC(=O)OC2=CC(OCC=C)=CC=C21 KWNHWLBNDYLDEC-UHFFFAOYSA-N 0.000 description 2
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- JKXQKGNGJVZKFA-UHFFFAOYSA-N 1-chloro-3-methylbut-2-ene Chemical compound CC(C)=CCCl JKXQKGNGJVZKFA-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- VIIIJFZJKFXOGG-UHFFFAOYSA-N 3-methylchromen-2-one Chemical compound C1=CC=C2OC(=O)C(C)=CC2=C1 VIIIJFZJKFXOGG-UHFFFAOYSA-N 0.000 description 1
- UDFPKNSWSYBIHO-UHFFFAOYSA-N 7-methoxy-4-methyl-1-benzopyran-2-one Chemical compound CC1=CC(=O)OC2=CC(OC)=CC=C21 UDFPKNSWSYBIHO-UHFFFAOYSA-N 0.000 description 1
- RSDDHGSKLOSQFK-PTNGSMBKSA-N Auraptene Natural products C1=CC(=O)OC2=CC(OC\C=C(C)/CCC=C(C)C)=CC=C21 RSDDHGSKLOSQFK-PTNGSMBKSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001500 aryl chlorides Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- RSDDHGSKLOSQFK-RVDMUPIBSA-N auraptene Chemical compound C1=CC(=O)OC2=CC(OC/C=C(C)/CCC=C(C)C)=CC=C21 RSDDHGSKLOSQFK-RVDMUPIBSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002350 geranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 150000004694 iodide salts Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- VPQAIISANYIHKZ-UHFFFAOYSA-N umbelliprenine Natural products CC(=CCCC=CCCC(=CCOc1ccc2C=CC(=O)Oc2c1)C)C VPQAIISANYIHKZ-UHFFFAOYSA-N 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- R is alkenyl, cycloalkenyl, alkadienyl, cycloalkadienyl, alkatrienyl, alkoxyalkadienyl, acyloxyalkadienyl, alkoxyalkenyl, cyclialkoxyalkenyl, aryl, alkaryl, or aralkyl and R is hydrogen or lower alkyl and such compounds having ultraviolet absorption maxima within the range of 2,900 A. up to about 3,400 A.
- the invention relates to compositions containing specific sun-screen compounds; to methods for protecting the human skin against the burning, tanning and degradation effects of sunlight, to certain new and useful sun-screen compounds, and in particular to cosmetic compositions incorporating the compounds including the novel compounds of this invention which are outstandingly useful for protecting the skin against sunlight.
- No one material possessing all of the desirable characteristics of sun screening compounds including: 1) stability; (2) lack of odor ;(3) no causation of irritation to the skin; (4) no causation of sensitization of the human skin on exposure to sun-light; (5) oil compatibility; (6) protection against both the burning rays and the tanning rays of the sun; having heretofore been described.
- Sun-screening compounds in general have been developed which afford satisfactory protection against the burning rays of the sun but which would permit the tanning rays to be transmitted. In the approximate range of from about 2,900 to 3,100 angstrom units are found the most detrimental burning wavelengths in the suns rays. The eifect of these wavelengths 0n the human skin is to produce a severe burning, reddening, blistering and edema which is characteristic of many burns. Obviously, this is not only not desirable from an esthetic point of view, but is a severe detriment to human health. In order, therefore, to overcome this effect of the burning rays of the sun, chemical compounds have been heretofore employed to screen out these burning rays.
- tanning is a desirable phenomenon and is somewhat related to good health
- the public has been educated to accept the numerous products currently available to screen out the burning rays of the sun but to permit tanning to occur.
- tanning may have some beneficial effects espeice cially in that it protects the skin from further burning where there is continued exposure to the sun, nevertheless, tanning in and of itself is associated with a general deterioration of the skin due to the effect of the actinic radiation thereon.
- tanning While the great majority of people are not severely affected by tanning, there are a great number who are so sensitive to even the tanning rays of the sun that exposure to these wavelengths creates serious health hazards.
- tanning is beautifying and would prefer to remain untanned. Consequently for those who must have protection against both burning and tanning rays of the sun, and for those who do not desire to be tanned, there has been a need for broad spectrum sun-screening compositions, which would give adequate protection to the skin, would be snfliciently stable under conditions of use to remain effective for several hours, which could be readily applied to the skin, which would be compatible with the various oily cosmetic compositions currently on the market, which would be aesthetically pleasing (for example, odorless) which would be non-irritating and non-sensitizing to the skin and which would not be readily removed such as by simple water-wash.
- the need for the latter characteristic is evident since it would leave one with a false sense of security if the material were readily removed as, for example, in bathing.
- non-sensitizing is used herein to mean that the compounds of this invention will not induce or enhance or augment photosensitivity of the skin or exposure to ultraviolet light for a wavelength in the range of from about 2900 A. to about 3400 A.
- composition (1) which has an outstanding filtering action on those rays of the sun from about 2900 A. to about 3400 A.; which range encompasses the burning and tanning wavelengths present in sunlight, and (2) which is odorless, non-irritating and non-sensitizing to the skin.
- compositions having the foregoing properties which is either substantially oil-miscible or capable of forming a non-granular smooth suspension in oils [such as those used in standard cosmetic sun-screen compositions for application to the skin] so as to be compatible with the various cosmetic compositions currently available to the public.
- One of the objects, therefore, of the present invention is to provide outstanding and useful compounds and compositions containing same which have excellent filtering action on the ultraviolet rays of solar light and particularly those wavelengths of from about 2,900 A. to about 3,400 A., as well as the ability to absorb ,the said rays even if the pH of the environment of the compound varies moderately.
- a class of compounds hereinafter to be described has outstanding screening characteristics for the burning and tanning rays of the sun, and particularly those wavelengths in the ultraviolet region of from about 2,900 A. to about 3,400 A.; (2) that such compounds have unexpected superior light fastness and stability upon exposure to ultraviolet radiation; (3) that such compounds maintain their screening characteristics notwithstanding a change in the pH of the environment of said compounds; (4) that such compounds are compatible (that is, form stable suspension or are miscible) with oily compositions suitable for application to the human skin; and (5 that such compounds are odonless, non-irritating and non-sensitizing to human skin.
- compositions containing 4-methyl-7-methoxy coumarin or other 4-methyl-7-lower alkoxy coumarin or esculin (6,7- dihydroxy coumarin-6-glucoside) have not been found to have all of the advantageous properties of the compounds of this invention; particularly with regard to compatibility with oily compositions, and consistency of sunscreening charcateristics (in the event of a change in the pH of the environment of the compound).
- R is alkenyl, cycloalkenyl, alkadienyl, cycloalkadienyl, alkatrientyl, alkoxyalkadienyl, acyloxyalkadienyl, alkoxyalkenyl, cyclialkoxyalkenyl, aryl, alkaryl or aralkyl and R is hydrogen or lower alkyl.
- Suitable R groups are:
- Suitable R groups are:
- R classes (2) and (4) and compounds of class (3) wherein R is lower alkyl are novel compounds.
- the novel methyl-substituted compounds of class (3) are surprisingly oil soluble.
- the general procedure for preparing the compounds found to be useful in this invention involves the reaction of a suitable halide with either 7-hydroxy coumarin (umbelliferone) or 7-hydroxy-4-lower alkyl coumarin.
- Suitable halide reactants are:
- alkenyl chlorides or bromides having 3 to 15 carbon atoms (1) alkenyl chlorides or bromides having 3 to 15 carbon atoms;
- alkatn'enyl chlorides of 8 to 15 carbon atoms
- the condensation is carried out in the presence of a base, such as an alkali metal carbonate or bicarbonate, for example, potassium carbonate or sodium carbonate and in an organic solvent compatible with the reactants preferably an alkyl or alicyclic ketone such as acetone or cyclohexanone.
- a base such as an alkali metal carbonate or bicarbonate, for example, potassium carbonate or sodium carbonate
- organic solvent compatible with the reactants preferably an alkyl or alicyclic ketone such as acetone or cyclohexanone.
- the reaction is carried out at atmospheric pressure and at reflux conditions. Higher temperatures of reaction, and consequently higher pressures, will reduce the time of reaction. It is desirable, to add a catalyst such as potassium or sodium iodide in order to speed the reaction. At higher temperatures, the period of reaction varies from about 10 hours up to about 30 hours depending upon the particular halide used as the reactant and the yield of product desired. At the end of the period of reaction, the reaction product is isolated in
- R classes 8, 9, 10, 11 and 12 may also be produced using the procedures set forth in Caglioti et al., Helvetica Chim. Acta, vol. XLII, Fasciculus VII, 1959, No. 273-4, pages 2557-2564.
- Suitable ethers useful in this invention are:
- CHz-O- Umbelliprenine having the structure:
- oily sunscreening compositions The range of usage of these compounds which are novel or which have been herein shown to be useful in oily sunscreening compositions is from about 1% up to about 10% (based on the weight of the final formula which is ready for use) with the preferred range being from about 1% up to about 6% by weight.
- Any oily carrier suitable for ap plication to the human skin may be used, for example, lanolin, cetyl alcohol, wheat germ oil, sesame oil, polyethylene glycol stearate (wherein the polyethylene glycol moiety has a molecular weight of less than 400), other fatty acid esters of polyethylene glycol (wherein the poly ethylene glycol moiety has a molecular weight of less than 400) and the like.
- application to the human skin may be made in any convenient and comfortable manner.
- An expedient application quantitiy is in the range of from up to about 200 milligrams (of active ultraviolet absorption compound (coumarin ether)) per quare meter of skin, depending upon the environment of exposure and the nature of the skin being exposed. Thus, for example, exposure to high intensity ultraviolet radiation of highly sensitive skin would necessitate application concentrations at the upper part of the foregoing range.
- Example II was carried out except that in place of myrcene hydrochloride, there were used the following halides in molar equivalent amounts:
- R is H or lower alkyl and wherein R is selected from the group consisting of alkadienyl of five to 20 carbon atoms, cycloalkadienyl of six to 10 carbon atoms, and cycloalkenyl of five to eight carbon atoms and intimately admixed, therewith, a carrier acceptable for topical application to human skin.
- a sun-screen composition comprising an effective sun-screening amount of a mixture of 7-geranoxy-4-methyl coumarin and 7-neryloxy-4-methyl coumarin and, intimately admixed therewith, a carrier acceptable for topical application to human skin.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
SUN-SCREENING COMPOSITIONS CONTAINING ESSENTIALLY COLORLESS, STABLE, ODORLESS, NON-IRRITATING, NON-SENSITIZING, AND OIL-CAMPATIBLE COUMARIN ETHER COMPOUNDS, SUCH COMPOUNDS HAVING THE FORMULA
4-R2,7-(R1-O-)COUMARIN
WHEREIN R1 IS ALKENYL, CYCLOALKENYL, CALKADIENYL, CYCLOALKADIENYL, ALKATRIENYL, ALKOXYALKADIENYL, ACYLOXYADIENYL, ALKOXYALKENYL, CYCLOIALKOXYALKENYL, ARYL, ALKARYL, OR ARALKYL AND R2 IS HYDROGEN OR LOWER ALKENYL AND SUCH COMPOUNDS HAVING ULTRAVIOLET ABSORPTION MAXIMA WITHIN THE RANGE OF 2,900 A. UP TO ABOUT 3,400 A.
4-R2,7-(R1-O-)COUMARIN
WHEREIN R1 IS ALKENYL, CYCLOALKENYL, CALKADIENYL, CYCLOALKADIENYL, ALKATRIENYL, ALKOXYALKADIENYL, ACYLOXYADIENYL, ALKOXYALKENYL, CYCLOIALKOXYALKENYL, ARYL, ALKARYL, OR ARALKYL AND R2 IS HYDROGEN OR LOWER ALKENYL AND SUCH COMPOUNDS HAVING ULTRAVIOLET ABSORPTION MAXIMA WITHIN THE RANGE OF 2,900 A. UP TO ABOUT 3,400 A.
Description
United States Patent U.S. Cl. 424-59 3 Claims ABSTRACT OF THE DISCLOSURE Sun-screening compositions containing essentially colorless, stable, odorless, non-irritating, non-sensitizing, and oil-compatible coumarin ether compounds, such compounds having the formula:
wherein R is alkenyl, cycloalkenyl, alkadienyl, cycloalkadienyl, alkatrienyl, alkoxyalkadienyl, acyloxyalkadienyl, alkoxyalkenyl, cyclialkoxyalkenyl, aryl, alkaryl, or aralkyl and R is hydrogen or lower alkyl and such compounds having ultraviolet absorption maxima within the range of 2,900 A. up to about 3,400 A.
This application is a division of applicants copending parent application Ser. No. 883,239, filed on Dec. 9, 1969, now U.S. Pat. 3,625,976.
The invention relates to compositions containing specific sun-screen compounds; to methods for protecting the human skin against the burning, tanning and degradation effects of sunlight, to certain new and useful sun-screen compounds, and in particular to cosmetic compositions incorporating the compounds including the novel compounds of this invention which are outstandingly useful for protecting the skin against sunlight.
No one material possessing all of the desirable characteristics of sun screening compounds including: 1) stability; (2) lack of odor ;(3) no causation of irritation to the skin; (4) no causation of sensitization of the human skin on exposure to sun-light; (5) oil compatibility; (6) protection against both the burning rays and the tanning rays of the sun; having heretofore been described.
Sun-screening compounds in general have been developed which afford satisfactory protection against the burning rays of the sun but which would permit the tanning rays to be transmitted. In the approximate range of from about 2,900 to 3,100 angstrom units are found the most detrimental burning wavelengths in the suns rays. The eifect of these wavelengths 0n the human skin is to produce a severe burning, reddening, blistering and edema which is characteristic of many burns. Obviously, this is not only not desirable from an esthetic point of view, but is a severe detriment to human health. In order, therefore, to overcome this effect of the burning rays of the sun, chemical compounds have been heretofore employed to screen out these burning rays. On the assumption and general acceptance by the public that tanning is a desirable phenomenon and is somewhat related to good health, the public has been educated to accept the numerous products currently available to screen out the burning rays of the sun but to permit tanning to occur. Within the recent years it has become generally accepted that while tanning may have some beneficial effects espeice cially in that it protects the skin from further burning where there is continued exposure to the sun, nevertheless, tanning in and of itself is associated with a general deterioration of the skin due to the effect of the actinic radiation thereon. While the great majority of people are not severely affected by tanning, there are a great number who are so sensitive to even the tanning rays of the sun that exposure to these wavelengths creates serious health hazards. Others have not quite accepted the notion that tanning is beautifying and would prefer to remain untanned. Consequently for those who must have protection against both burning and tanning rays of the sun, and for those who do not desire to be tanned, there has been a need for broad spectrum sun-screening compositions, which would give adequate protection to the skin, would be snfliciently stable under conditions of use to remain effective for several hours, which could be readily applied to the skin, which would be compatible with the various oily cosmetic compositions currently on the market, which would be aesthetically pleasing (for example, odorless) which would be non-irritating and non-sensitizing to the skin and which would not be readily removed such as by simple water-wash. The need for the latter characteristic is evident since it would leave one with a false sense of security if the material were readily removed as, for example, in bathing.
The term non-sensitizing is used herein to mean that the compounds of this invention will not induce or enhance or augment photosensitivity of the skin or exposure to ultraviolet light for a wavelength in the range of from about 2900 A. to about 3400 A.
In order, therefore, to achieve the ends of the present invention, it is necessary to provide a composition (1) which has an outstanding filtering action on those rays of the sun from about 2900 A. to about 3400 A.; which range encompasses the burning and tanning wavelengths present in sunlight, and (2) which is odorless, non-irritating and non-sensitizing to the skin.
It is further necessary to provide a composition having the foregoing properties which is either substantially oil-miscible or capable of forming a non-granular smooth suspension in oils [such as those used in standard cosmetic sun-screen compositions for application to the skin] so as to be compatible with the various cosmetic compositions currently available to the public.
It is further necessary to provide a composition having the foregoing properties, the ultraviolet radiation absorption properties of which will not be transformed as a result of a change in the pH of the environment of the compound.
One of the objects, therefore, of the present invention is to provide outstanding and useful compounds and compositions containing same which have excellent filtering action on the ultraviolet rays of solar light and particularly those wavelengths of from about 2,900 A. to about 3,400 A., as well as the ability to absorb ,the said rays even if the pH of the environment of the compound varies moderately.
It is still another object of the present invention to provide oily compositions, and particularly cosmetic compositions, which may be applied to the human skin to protect it against the burning and tanning rays of the sun and which are odorless, non-irritating and non-sensitizing to the skin;
It is a still further object of the present invention to provide processes for preparing certain of the compounds with which the present invention is concerned and further, to provide processes for protecting the human skin against the burning and tanning rays of the sun.
Other objects will appear hereinafter as the description proceeds.
In accordance with the objects of the present invention, it has now been discovered that (1) a class of compounds hereinafter to be described has outstanding screening characteristics for the burning and tanning rays of the sun, and particularly those wavelengths in the ultraviolet region of from about 2,900 A. to about 3,400 A.; (2) that such compounds have unexpected superior light fastness and stability upon exposure to ultraviolet radiation; (3) that such compounds maintain their screening characteristics notwithstanding a change in the pH of the environment of said compounds; (4) that such compounds are compatible (that is, form stable suspension or are miscible) with oily compositions suitable for application to the human skin; and (5 that such compounds are odonless, non-irritating and non-sensitizing to human skin.
Known compositions containing 4-methyl-7-hydroxycoumarin [see British Pat. 464,732 and Gregoire et al., Ann. Pharm. Franc, 9, 493513 (1951)] have not been found to have all of the foregoing advantages. Such compounds do not have such stability that their screening characteristics are maintained in the event of a change in the pH of the environment of the compound; nor are they considered to be compatible with oily compositions suitable for application to the human skin, as are the compounds of this invention. By the same token, known compositions containing 4-methyl-7-methoxy coumarin or other 4-methyl-7-lower alkoxy coumarin or esculin (6,7- dihydroxy coumarin-6-glucoside) have not been found to have all of the advantageous properties of the compounds of this invention; particularly with regard to compatibility with oily compositions, and consistency of sunscreening charcateristics (in the event of a change in the pH of the environment of the compound).
The compounds found to be useful in the present invention and those which are employed in the compositions and processes of this invention have the following general formulae:
wherein R is alkenyl, cycloalkenyl, alkadienyl, cycloalkadienyl, alkatrientyl, alkoxyalkadienyl, acyloxyalkadienyl, alkoxyalkenyl, cyclialkoxyalkenyl, aryl, alkaryl or aralkyl and R is hydrogen or lower alkyl.
Suitable R groups are:
(1);alkenyl of 3 to 15 carbon atoms;
(2) cycloalkenyl of 5 to 8 carbon atoms;
(3) alkadienyl of 5 to 20 carbon atoms;
(4) cycloalkadienyl of 6 to atoms;
(5) aralkyl of 7 to 30 carbon atoms;
(6) alkaryl of 7 to 30 carbon atoms;
(7) aryl of 6 to 14 carbon atoms;
(8) alkatrienyl of 8 to carbon atoms;
(9) alkoxyalkadienyl of 8 to 30 carbon atoms;
( 10) acyloxyalkadienyl of 8 to 30 carbon atoms; (11) alkoxyalkenyl of 8 to 30 carbon atoms;
(12) cyclialkoxyalkenyl of 8 to 30 carbon atoms.
Suitable R groups are:
(1) hydrogen; (2) methyl; (3) ethyl; -p py (5 -p py (6) n-butyl; (7) 2-butyl; (8) 3-butyl.
Compounds of R classes (2) and (4) and compounds of class (3) wherein R is lower alkyl are novel compounds. The novel methyl-substituted compounds of class (3) are surprisingly oil soluble.
The general procedure for preparing the compounds found to be useful in this invention involves the reaction of a suitable halide with either 7-hydroxy coumarin (umbelliferone) or 7-hydroxy-4-lower alkyl coumarin. Suitable halide reactants are:
(1) alkenyl chlorides or bromides having 3 to 15 carbon atoms;
(2) cycloalkenyl chlorides or bromides having 3 to 15 carbon atoms;
(3) alkadienyl chlorides or bromides having from 5 to 20 carbon atoms;
(4) cycloalkadienyl chlorides or bromides having from 6 to 10 carbon atoms;
(5) aralkyl chlorides or bromides having from 7 to 30 carbon atoms;
(6) alkaryl chlorides and bromides having from 7 to 30 carbon atoms;
(7) aryl chlorides, bromides and iodides having from 6 to 14 carbon atoms;
(8) alkatn'enyl chlorides of 8 to 15 carbon atoms;
(9) alkoxyalkadienyl chlorides of 8 to 30 carbon atoms;
(10) acyloxyalkadienyl chlorides of 8 to 30 carbon atoms;
(11) alkoxyalkenyl chlorides of 8 to 30 carbon atoms;
(12) cyclialkoxyalkenyl chlorides of 8 to 30 carbon atoms.
The condensation is carried out in the presence of a base, such as an alkali metal carbonate or bicarbonate, for example, potassium carbonate or sodium carbonate and in an organic solvent compatible with the reactants preferably an alkyl or alicyclic ketone such as acetone or cyclohexanone. Most preferably in view of convenience and economy the reaction is carried out at atmospheric pressure and at reflux conditions. Higher temperatures of reaction, and consequently higher pressures, will reduce the time of reaction. It is desirable, to add a catalyst such as potassium or sodium iodide in order to speed the reaction. At higher temperatures, the period of reaction varies from about 10 hours up to about 30 hours depending upon the particular halide used as the reactant and the yield of product desired. At the end of the period of reaction, the reaction product is isolated in the usual manner by means of crystallization or distillation where feasible.
Compounds of R classes 8, 9, 10, 11 and 12 may also be produced using the procedures set forth in Caglioti et al., Helvetica Chim. Acta, vol. XLII, Fasciculus VII, 1959, No. 273-4, pages 2557-2564.
Among suitable ethers useful in this invention are:
7-allyloxy-4-methyl coumarin;
7 3-methyl-2-butenl-oxy -4-methyl coumarin;
7-neryloxy-4-butyl coumarin;
7-geranyloxy-4-n-propyl coumarin;
7-geranyloxy-4-( l-n-butyl) coumarin;
7-benzoxy-4-methy1 coumarin;
7-benzoxy-4-ethyl coumarin;
7-allyloxy coumarin;
7-(3-methyl cyclo hex-2-en) oxy-4-methyl coumarin;
7-geranyloxy-4-methyl coumarin;
7-neryloxy-4-methyl coumarin;
7-( 3-methyl-2-buten-1-oxy) coumarin;
7- 3-methyl-2-buten-1-oxy) -4-n-propy1 coumarin;
7-benzoxy coumarin;
7-(6-ethyl-cycloocta-2,4-dien) oxy-4-methy coumarin;
A mixture of 7-geranyloxy and 7-nery1oxy coumarin;
A mixture of 7-geranyloxy and 7-nery1oxy-4-methyl coumarins.
The compound of the structure:
CHz-O- Umbelliprenine having the structure:
The range of usage of these compounds which are novel or which have been herein shown to be useful in oily sunscreening compositions is from about 1% up to about 10% (based on the weight of the final formula which is ready for use) with the preferred range being from about 1% up to about 6% by weight. Any oily carrier suitable for ap plication to the human skin may be used, for example, lanolin, cetyl alcohol, wheat germ oil, sesame oil, polyethylene glycol stearate (wherein the polyethylene glycol moiety has a molecular weight of less than 400), other fatty acid esters of polyethylene glycol (wherein the poly ethylene glycol moiety has a molecular weight of less than 400) and the like. After producing the formulation, application to the human skin may be made in any convenient and comfortable manner. An expedient application quantitiy is in the range of from up to about 200 milligrams (of active ultraviolet absorption compound (coumarin ether)) per quare meter of skin, depending upon the environment of exposure and the nature of the skin being exposed. Thus, for example, exposure to high intensity ultraviolet radiation of highly sensitive skin would necessitate application concentrations at the upper part of the foregoing range.
The following examples serve only to illustrate the present invention. Percentages by weight are set forth therein unless otherwise indicated.
EXAMPLE I Preparation of a mixture of 7-geranyloxy-4-methyl coumain and 7-neryloxy-4methy1 coumarin To a flash fitted with a stirrer, a condenser and a thermometer was added 200 g. (1.14 moles) 4-methyl umbelliferone 280 g. (1.2 moles 77%) cold myrcene hydrochloride, consisting predominantly of geranyl and neryl chlorides produced by the process of US. Pat. 2,882,323, 680 g. of potassium carbonate, 10 g. of potassium iodide and 3.5 liters of acetone. The mixture was stirred and refiuxed for 2-0 hours. The solution was filtered, and the supernatant liquid was retained for subsequent workup. Solid residue from this filtration was dissolved in a 2 N NaOH solution and this solution was then extracted with three 500 ml. volumes of CH2C12.TT1 organic phases (the aforesaid supernatant liquid and the CH Cl extracts) were combined and washed with two equal volumes of 2 N sodium hydroxide solution, followed by two equal volumes of water. 310 g. of crude reaction material was thereby produced. This crude product was steam distilled, to give 55 g. of steam volatiles. The residue after steam distillation was taken up in methylene chloride, and separated from the water layer. The organic layer was subjected to crystallization from petroleum ether to give 225 g. of a mixture of cis and trans isomers, 7-geranyloxy-4-methyl coumarin and 7-neryloxy-4-methyl coumarin. The following structures were confirmed by NMR data:
I o@i )=o O- 0 O I and A a (7-neryloxy coumarin) (7-geranyloxy coumarin) e at 3220 A. -=18100 (Extinction Coefficient) NMR data. ppm. 1.58, '1.63 (singlet, 3H each) 1.7 1(doublet a, H, J=2cps 2.08 (broad, triplet, 4H, Cfi Cl-k), 2.39
(singlet an, on=b 4.57 (triplet, 2H H(:CO), 5.04
5. 41(broa 6. (2g, two aromatic protons), 7.54 (doublet, 1H, aromatic J =7) EXAMPLE II The product of Example I was incorporated into a neutral sun-screen cream as follows:
Percent weight The mixture of 7-neryloxy-4-methyl coumarin and 7-geranyloxy-4-methyl coumarin (Produced in Ex- The unexpected high miscibility of the product of Example I made it possible to formulate the above homogeneous cream. This cream was then used separately by five people in a bathing procedure, and thereafter the five persons were exposed to the summer afternoon sun for two hours. A similar group of five persons used a similar cream but devoid of the product of Example I, and these individuals were exposed similarly to the first group. All of the persons in the second group, after exposure, showed considerable reddening of the skin whereas none of the persons in the first group had any visible evidence of sunburn. This demonstrates the sunscreening properties of the compound of Example I.
EXAMPLES III-V In the following examples, Example I was carried out except that in place of myrcene hydrochloride, there were used the following halides in molar equivalent amounts:
b ltraviolet Halide Reaction datals at Ex. reactant product 3620A] III. Allyl ch1oride 7-allyloxy-4-methyl coumarin 17, 500
IV Prenyl chloride. 7(3-methyl-2-buten-1-oxy)-4- 17,600
methyl coumarin.
V Benzyl chloride. 7-benzoxy-4-methyl coumarin.-- 17,650
EXAMPLES VI-VIII formula:
8 wherein R is H or lower alkyl and wherein R is selected from the group consisting of alkadienyl of five to 20 carbon atoms, cycloalkadienyl of six to 10 carbon atoms, and cycloalkenyl of five to eight carbon atoms and intimately admixed, therewith, a carrier acceptable for topical application to human skin.
2. A sun-screen composition comprising an effective sun-screening amount of a compound selected from group consisting of:
7-allyloxy-4-methyl coumarin 7(3-methyl-2-buten-1-oxy)-4-methyl coumarin 7-benzoxy-4-methyl coumarin 7-geranyloxy-4-rmethyl coumarin 7-neryloxy-4-methyl coumarin 7-allyloxy coumarin 7(3-methyl-2-buten-1-oxy) coumarin and 7-benzoxy coumarin and, intimately admixed therewith, a carrier acceptable for topical application to human skin.
3. A sun-screen composition comprising an effective sun-screening amount of a mixture of 7-geranoxy-4-methyl coumarin and 7-neryloxy-4-methyl coumarin and, intimately admixed therewith, a carrier acceptable for topical application to human skin.
References Cited Giese et al., J. Am. Pharm. Assoc., vol. 39, pp. 30-36 (1950).
Pernich et al., J. Soc. Cosmetic Chemists, vol. 2, p. 92 99 (1950).
ALBERT T. MEYERS, Primary Examiner D. B. MOYER, Assistant Examiner US. Cl. X.R. 25 2-300
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US00165343A US3712947A (en) | 1969-12-09 | 1971-07-22 | Compositions containing coumarin ether sun-screening compounds |
| BR4807/72A BR7204807D0 (en) | 1971-07-22 | 1972-07-19 | LOADING IRON |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US883239A US3625976A (en) | 1969-12-09 | 1969-12-09 | Coumarin ether sun-screening compounds |
| US00165343A US3712947A (en) | 1969-12-09 | 1971-07-22 | Compositions containing coumarin ether sun-screening compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3712947A true US3712947A (en) | 1973-01-23 |
Family
ID=27183887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US00165343A Expired - Lifetime US3712947A (en) | 1969-12-09 | 1971-07-22 | Compositions containing coumarin ether sun-screening compounds |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3712947A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4333920A (en) * | 1979-02-23 | 1982-06-08 | Van Dyk & Company, Inc. | Benzalphthalides and broad spectrum sun screens |
| US5100914A (en) * | 1988-10-13 | 1992-03-31 | Basf Aktiengesellschaft | Arylalkoxycoumarins |
| US20080038335A1 (en) * | 2005-04-19 | 2008-02-14 | Shanghai Tianbo Biotechnology Co., Ltd. | Method, formulation, and use thereof for improved oral absorption of pharmaceuticals or nutrients |
| US20100227039A1 (en) * | 2009-03-03 | 2010-09-09 | Givaudan S.A. | Off-Taste Masking |
-
1971
- 1971-07-22 US US00165343A patent/US3712947A/en not_active Expired - Lifetime
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4333920A (en) * | 1979-02-23 | 1982-06-08 | Van Dyk & Company, Inc. | Benzalphthalides and broad spectrum sun screens |
| US5100914A (en) * | 1988-10-13 | 1992-03-31 | Basf Aktiengesellschaft | Arylalkoxycoumarins |
| US20080038335A1 (en) * | 2005-04-19 | 2008-02-14 | Shanghai Tianbo Biotechnology Co., Ltd. | Method, formulation, and use thereof for improved oral absorption of pharmaceuticals or nutrients |
| US20100227039A1 (en) * | 2009-03-03 | 2010-09-09 | Givaudan S.A. | Off-Taste Masking |
| CN102413713A (en) * | 2009-03-03 | 2012-04-11 | 奇华顿股份有限公司 | Odor masking |
| US8329239B2 (en) * | 2009-03-03 | 2012-12-11 | Givandan S.A. | Off-taste masking |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3625976A (en) | Coumarin ether sun-screening compounds | |
| US4724137A (en) | s-Triazine derivatives and their use as sun screen agents | |
| US4144325A (en) | Method of and composition for preventing sunburn while affording tanning | |
| US4867964A (en) | Cosmetic composition containing hydroxylated chalcone derivatives and its use for protecting the skin and the hair against luminous radiations, new hydroxylated chalcone derivatives employed and process for their preparation | |
| US4098882A (en) | Anti-solar composition | |
| US5175340A (en) | New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics | |
| US5208012A (en) | Anti-inflammatory or anti-sunburn cosmetic composition | |
| DE4426216A1 (en) | Benzylidene Norcampher Derivatives | |
| AU5416701A (en) | Compositions comprising flavylium salt compounds which are unsubstituted in position 3, for colouring the skin, and uses thereof | |
| KR20060052830A (en) | Dibenzoilmethane derivative compounds, the use thereof in the form of photoactivable solar filters and cosmetic compositions containing said compounds | |
| JPH01299210A (en) | Cosmetic composition containing di- organopolysiloxane | |
| AU5417001A (en) | Compositions comprising at least one mono- or polycarbonyl self-tanning agent and a flavylium salt compound which is unsubstituted in position 3, for colouring the skin, and uses thereof | |
| US4731200A (en) | Alcoholic or aqueous-alcoholic compositions containing natural essences and benzylidene-camphor derivatives | |
| KR0152122B1 (en) | Use of 6,6-dimethyl-2-acylcyclohex-4-ene-1,3-dione derivatives in the field of solar protection in the cosmetic industry, preparations containing these derivatives, 6,6-dimethyl-2- Acylcyclohex-4-ene-1,3-dione derivative and its manufacturing method | |
| JPS6112612A (en) | Sun-screening agent-containing composition | |
| EP0528380B1 (en) | Alkyl-aryl 1,3-propanedion silicone derivative and an external preparation for skin with the derivative compounded therein | |
| JP3088224B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
| US4438094A (en) | Cosmetic formulations containing oxyethylated diphenylamines as sun screen agents | |
| JP3534938B2 (en) | Hydantoin derivatives, ultraviolet absorbers and skin external preparations | |
| JP3170386B2 (en) | Silicone hydantoin derivatives, UV absorbers and skin external preparations | |
| DE3843325C2 (en) | Unsaturated 3-benzylidene-camphor derivatives, processes for their preparation, cosmetic products containing these compounds and processes for protecting the skin and for protecting a cosmetic product | |
| DE2160136A1 (en) | SUN PROTECTION | |
| JP3976816B2 (en) | Hydantoin derivatives, UV absorbers and skin external preparations | |
| US3965144A (en) | Carbanilate compound for erythemal protection | |
| WO2007040171A1 (en) | Sunscreen cosmetic composition |